BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15986635)

  • 1. [Gynecomastia (of the adult)].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Jun; 94(22):903-8; quiz 909. PubMed ID: 15986635
    [No Abstract]   [Full Text] [Related]  

  • 2. Gynecomastia associated with calcium channel blocker therapy.
    Tanner LA; Bosco LA
    Arch Intern Med; 1988 Feb; 148(2):379-80. PubMed ID: 3341839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
    Boyd IW
    Med J Aust; 1994 Sep; 161(5):328. PubMed ID: 7830672
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to short-acting nifedipine in hypertensive crises.
    Spizzirri F; Rahman R
    Pediatr Nephrol; 1999 May; 13(4):366. PubMed ID: 10454793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Korinfar in the treatment of patients with arterial hypertension].
    Lautsevichus LZ; Kibarskis KhKh; Razukas VA; Nauiokaĭtene RS
    Vrach Delo; 1986 Sep; (9):26-8. PubMed ID: 3788106
    [No Abstract]   [Full Text] [Related]  

  • 6. The nifedipine scare in hypertension: fact or fiction.
    Gambhir DS
    Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is there a risk in treatment of hypertension with nifedipine?].
    Düsing R
    Internist (Berl); 1996 Sep; 37(9):939-41. PubMed ID: 8964691
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-acting nifedipine.
    Gauthier B; Trachtman H
    Pediatr Nephrol; 1997 Dec; 11(6):786-7. PubMed ID: 9438668
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine and other calcium channel blockers.
    Pahor M
    Eur Heart J; 1997 Jan; 18(1):168. PubMed ID: 9049532
    [No Abstract]   [Full Text] [Related]  

  • 10. Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia.
    Jacobs U; Klein B; Klehr HU
    Transplant Proc; 1994 Dec; 26(6):3122. PubMed ID: 7998089
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nilvadipin for nifedipine induced calf edema. Results of a double blind randomized comparative study].
    Fortschr Med Monogr; 1994; 70():1-11. PubMed ID: 7633838
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of antihypertension drugs and their combinations in the non-treated hypertension].
    Ruksin VV; Grishin OV; Chiritso MM
    Med Tr Prom Ekol; 2013; (5):7-11. PubMed ID: 24000722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
    Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A
    Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885
    [No Abstract]   [Full Text] [Related]  

  • 17. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists in the therapy of essential arterial hypertension. Analysis of the results obtained with 3 drugs].
    Bossini A; Di Veroli C; Amoroso A
    Recenti Prog Med; 1985 Oct; 76(10):505-14. PubMed ID: 2935907
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guideline--gynecomastia].
    Schreiber G; Schanz S; Köhn FM
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):561-5. PubMed ID: 15967017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation and management of gynecomastia].
    Meyer P
    Rev Med Suisse; 2009 Apr; 5(198):783-7. PubMed ID: 19418981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.